Metabolic engineering of Escherichia coli for the production of cinnamaldehyde

Hyun Bae Bang, Yoon Hyeok Lee, Sun Chang Kim, Chang Keun Sung, Ki Jun JeongMicrobial 2016 · DOI

TL;DR

Researchers have engineered Escherichia coli to produce cinnamaldehyde, a natural nematicide, by introducing a synthetic biosynthesis pathway. They significantly boosted production by optimizing the precursor L-phenylalanine pathway, achieving a 35-fold increase and demonstrating the engineered strain's nematicidal efficacy.

What Problem Does This Paper Address?

Plant-parasitic nematodes cause significant agricultural losses, leading to a reliance on chemical pesticides. However, these chemicals have drawbacks, including non-selectivity and potential environmental harm. Cinnamaldehyde, a compound found in cinnamon, shows potent nematicidal activity and is a promising natural alternative. Currently, cinnamaldehyde is produced via chemical synthesis or extraction from cinnamon bark, both of which have limitations (e.g., difficulty in purification, plant resource consumption). This paper addresses the need for an eco-friendly and efficient biological platform for cinnamaldehyde production, specifically by engineering E. coli.

Methods

The core of this research involves metabolic engineering of E. coli. The authors first constructed a synthetic biosynthesis pathway for cinnamaldehyde by introducing three key enzymes: phenylalanine-ammonia lyase (PAL), 4-coumarate:CoA ligase (4CL), and cinnamoyl-CoA reductase (CCR). They screened different enzyme sources (plant vs. bacterial) to identify the most effective ones for E. coli.

To enhance production, they then engineered the L-phenylalanine biosynthesis pathway, the precursor for cinnamaldehyde. This involved a multi-step process of gene deletions in E. coli W3110 to:

  • Moderate substrate uptake: Deleting the crr gene to reduce glucose uptake via the phosphotransferase system (PTS).
  • Alleviate feedback inhibition: Deleting the tyrR gene to remove tight regulation of aromatic amino acid (AAA) synthesis genes.
  • Redirect carbon flow: Deleting trpE and tyrA genes to prevent carbon loss to tryptophan and tyrosine biosynthesis.
  • Enrich precursors: Deleting the pykA gene to increase phosphoenolpyruvate (PEP) availability for the shikimate pathway.

Further improvements were achieved through plasmid-based overexpression of key enzymes in the shikimate pathway (e.g., engineered aroG, ydiB, arok, pheA) and genes involved in glucose uptake (galP, glk).

Finally, the nematicidal activity of the produced cinnamaldehyde was evaluated using Bursaphelenchus xylophilus nematodes.

Datasets

Not discussed in the paper. The study relies on in vitro enzyme assays and in vivo microbial cultivation and analysis.

Key Insights and Ideas

  • Enzyme source matters: Bacterial PAL (S. maritimus) and bacterial 4CL (S. coelicolor) were found to be more effective than their plant counterparts for cinnamaldehyde biosynthesis in E. coli.
  • Multi-gene deletion strategy: Systematically deleting genes involved in competing pathways and regulatory mechanisms was crucial for increasing the intracellular pool of the precursor L-phenylalanine.
  • Synergistic pathway engineering: Combining the synthetic cinnamaldehyde biosynthesis pathway with an engineered L-phenylalanine pathway led to a dramatic increase in product titer.
  • Proof of concept for natural product synthesis: This work demonstrates the potential of E. coli as a versatile platform for producing valuable natural compounds with applications beyond flavorings, such as biopesticides.
  • Nematicidal efficacy confirmed: The E. coli-produced cinnamaldehyde exhibited comparable nematicidal activity to commercially available cinnamaldehyde, validating its functional relevance.

Key Results

  • The engineered E. coli strain (YHP05 harboring pHB-CAD and pYHP) produced 75 mg/L of cinnamaldehyde. This represents a 35-fold improvement compared to the wild-type strain expressing the biosynthesis genes.
  • The engineered L-phenylalanine precursor pathway in strain YHP05 achieved a production titer of 3.91 g/L of L-phenylalanine, a significant increase from the parental strain's 0.24 g/L.
  • The nematicidal assay showed that the E. coli-produced cinnamaldehyde (at 60 mg/L) killed nearly all nematodes within 4 hours, comparable to commercial cinnamaldehyde.

Limitations and Future Work

  • Production Titer: While a 35-fold improvement is substantial, the achieved titer of 75 mg/L is still considered insufficient for commercialization, requiring further improvements to reach gram-scale titers.
  • Enzyme Activity: The authors suggest that the relatively poor activities of the biosynthetic enzymes (SmPAL, ScCCL, AtCCR) might limit the overall conversion rate.
  • Industrial Scale-up: The current work was performed in flask cultivations. Future work will focus on optimizing fed-batch cultivation conditions, media compositions, and feeding strategies for industrial-scale production.
  • Protein Engineering: Further engineering of enzyme activities or the development of protein scaffolds for modular pathway control are proposed to enhance production titers.

Summary updated

Abstract

As a potential natural pesticide, cinnamaldehyde was successfully produced in E. coli by construction of the biosynthesis pathway and, its production titer was also significantly increased by engineering the metabolic pathway of L-phenylalanine.
BibTeX
@inproceedings{bang2016metabolic,
  author = {Hyun Bae Bang and Yoon Hyeok Lee and Sun Chang Kim and Chang Keun Sung and Ki Jun Jeong},
  title = {{Metabolic engineering of Escherichia coli for the production of cinnamaldehyde}},
  booktitle = {Microbial},
  year = {2016},
  doi = {10.1186/s12934-016-0415-9},
}
Figure